Zeteo Tech, Inc. — Department of Defense STTR Phase I: AF18C-T001
Zeteo Tech, Inc. — STTR Phase I award from Department of Defense.
Phase I STTR feasibility signal
- Phase I awards fund proof-of-concept work. For capture teams, they mark early interest from Department of Defense in a technical approach.
- Watch for Phase II follow-ons from the same firm/topic family — that conversion path is where budgets and transition pressure rise.
- Obligated amount $149,749. Cross-check similar awards in the same agency and technology tags for going-rate context.
- Topic code AF18C-T001 links this award to a solicitation family — search the same topic stem for incumbents and recompete timing.
- Amount
- $149,749
- Agency
- Department of Defense · Air Force
- Program / Phase
- STTR · Phase I
- Topic
- AF18C-T001
- Solicitation
- 18.C
- NAICS
- —
- Place of performance
- MD
- Period
- 2019-04-25 → 2020-04-25
Description
This effort will investigate the use MALDI (matrix assisted laser desorption/ionization)-TOF (time-of-flight) mass spectrometer as a platform for rapid analysis of biomarkers in operational and training environments. In Phase I samples, will be acquired from human subjects under stress. These samples will be processed for analysis using our prototype portable MALDI TOF mass spectrometer. Samples will also be analyzed with a high performance, commercial mass spectrometer for comparison, and requirements for the biomarker detection system will be determined. Additionally, requirements for a fieldable, handheld sample collection system for blood, saliva and sweat samples for later phases of the development.